Medicamen Organics Limited (NSE:MEDIORG)

Market Cap	400.14M
Revenue (ttm)	381.88M
Net Income (ttm)	40.47M
Shares Out	11.70M
EPS (ttm)	3.66
PE Ratio	9.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Average Volume	8,600
Open	34.30
Previous Close	36.00
Day's Range	34.20 - 35.60
52-Week Range	19.60 - 72.60
Beta	n/a
RSI	36.33
Earnings Date	Aug 14, 2025

About Medicamen Organics

Medicamen Organics Limited engages in the developing, manufacturing, and distribution of a range of pharmaceutical dosage in India and internationally. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It markets i...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 62
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDIORG

Financial Performance

In 2024, Medicamen Organics's revenue was 381.88 million, an increase of 51.11% compared to the previous year's 252.72 million. Earnings were 40.47 million, an increase of 54.22%.